Biden to Announce $150 Million Boost for Advanced Cancer Surgery Technology
On Tuesday, President Joe Biden is set to announce a new allocation of $150 million in federal funding to develop advanced technologies aimed at improving cancer surgery outcomes. The announcement will be made during Biden’s visit to New Orleans and represents the latest step in the administration’s “Cancer Moonshot” initiative, a program led by the President and First Lady Jill Biden. The initiative’s ambitious goal is to reduce the US cancer death rate by at least 50% by 2047.
Advancing Surgical Precision in Cancer Treatment
Each year, nearly two million Americans receive a diagnosis of solid tumor cancers, and surgery is often the first line of treatment. The new funding aims to support the development of next-generation microscopes and imaging technologies. These advancements are expected to enhance the precision of surgical procedures, making it easier for surgeons to successfully remove cancerous tumors while minimizing harm to surrounding healthy tissue. The White House emphasized that this could significantly reduce the need for repeat surgeries and improve patient outcomes, ultimately saving and extending lives.
Continued Investment in the Cancer Moonshot Initiative
This $150 million investment is part of a broader effort by the Biden administration to accelerate progress in cancer prevention, detection, and treatment. Over the first two years of the Cancer Moonshot initiative, more than $400 million has been invested to fast-track developments in these areas. The initiative reflects a strong commitment to advancing medical research and improving care for cancer patients across the country.
Recognized Institutions to Receive Funding
Eight institutions have been selected to receive the new funding, including Dartmouth College, Johns Hopkins University, and the University of Washington. These institutions will play a key role in developing the cutting-edge technologies that are central to the Cancer Moonshot’s mission. By supporting research at these leading institutions, the administration hopes to drive significant advancements in cancer treatment.
